<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2017//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_170101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">28841826</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>26</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>31</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-244X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Aug</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC psychiatry</Title>
                <ISOAbbreviation>BMC Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme.</ArticleTitle>
            <Pagination>
                <MedlinePgn>308</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12888-017-1468-y</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Little is known about patients with a first episode of psychosis (FEP) who had first presented to prodromal services with an &quot;at risk mental state&quot; (ARMS) before making the transition to psychosis. We set out to identify the proportion of patients with a FEP who had first presented to prodromal services in the ARMS state, and to compare these FEP patients with FEP patients who did not have prior contact with prodromal services.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this study information on 338 patients aged ≤37 years who presented to mental health services between 2010 and 2012 with a FEP was examined. The data on pathways to care, clinical and socio-demographic characteristics were extracted from the Biomedical Research Council Case Register for the South London and Maudsley NHS Trust.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Over 2 years, 14 (4.1% of n = 338) young adults presented with FEP and had been seen previously by the prodromal services. These ARMS patients were more likely to enter their pathway to psychiatric care via referral from General Practice, be born in the UK and to have had an insidious mode of illness onset than FEP patients without prior contact with the prodromal services.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In the current pathways to care configuration, prodromal services are likely to prevent only a few at-risk individuals from transitioning to psychosis even if effective preventative treatments become available.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ajnakina</LastName>
                    <ForeName>Olesya</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3987-1236</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK. olesya.ajnakina@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Craig</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Society and Mental Health Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gayer-Anderson</LastName>
                    <ForeName>Charlotte</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Society and Mental Health Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oduola</LastName>
                    <ForeName>Sherifat</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>NIHR Biomedical Research Centre, David Goldberg Building, Institute of Psychiatry, Psychology &amp; Neuroscience, Kings College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bourque</LastName>
                    <ForeName>François</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Society and Mental Health Research Group, Health Service and Population Research Department, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bramley</LastName>
                    <ForeName>Sally</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guy's, King's and St Thomas' School of Medical Education, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williamson</LastName>
                    <ForeName>Jessica</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Violence Prevention Research Unit Queen Mary University of London &amp; East London NHS Foundation Trust, Garrod Building, Turner Street, London, E1 2AD, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>MacCabe</LastName>
                    <ForeName>James H</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>08</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Psychiatry</MedlineTA>
            <NlmUniqueID>100968559</NlmUniqueID>
            <ISSNLinking>1471-244X</ISSNLinking>
        </MedlineJournalInfo>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2011 Feb;41(2):243-50</RefSource>
                <PMID Version="1">20406524</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2007 Nov;96(1-3):206-14</RefSource>
                <PMID Version="1">17719746</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Psychiatr Scand. 2010 May;121(5):371-6</RefSource>
                <PMID Version="1">20085554</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Soc Psychiatry Psychiatr Epidemiol. 2008 Dec;43(12):975-82</RefSource>
                <PMID Version="1">18604616</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Stat Med. 2006 Dec 30;25(24):4216-26</RefSource>
                <PMID Version="1">16955543</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Early Interv Psychiatry. 2007 Feb;1(1):97-103</RefSource>
                <PMID Version="1">21352113</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2014 Mar;153(1-3):1-8</RefSource>
                <PMID Version="1">24529612</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Psychiatry. 2013 Jun;28(5):315-26</RefSource>
                <PMID Version="1">23137782</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Health Care Poor Underserved. 2008 Aug;19(3):874-93</RefSource>
                <PMID Version="1">18677076</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Med Inform Decis Mak. 2013 Jul 11;13:71</RefSource>
                <PMID Version="1">23842533</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>World Psychiatry. 2010 Jun;9(2):123</RefSource>
                <PMID Version="1">20671903</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2005 Apr;186:290-6</RefSource>
                <PMID Version="1">15802684</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2007 Mar;91(1-3):87-96</RefSource>
                <PMID Version="1">17306506</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2004 Jul;185:18-24</RefSource>
                <PMID Version="1">15231551</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2003 Mar 1;60(1):21-32</RefSource>
                <PMID Version="1">12505135</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2006 Mar;63(3):250-8</RefSource>
                <PMID Version="1">16520429</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 1996;22(2):283-303</RefSource>
                <PMID Version="1">8782287</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Aust N Z J Psychiatry. 2005 Nov-Dec;39(11-12):964-71</RefSource>
                <PMID Version="1">16343296</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cancer Treat Rep. 1985 Oct;69(10):1071-77</RefSource>
                <PMID Version="1">4042087</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2006 May;84(1):57-66</RefSource>
                <PMID Version="1">16630707</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2000 Dec;177:511-5</RefSource>
                <PMID Version="1">11102325</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2006 Nov;189:446-52</RefSource>
                <PMID Version="1">17077436</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2012 Mar;69(3):220-9</RefSource>
                <PMID Version="1">22393215</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013 Sep 12;8(9):e74262</RefSource>
                <PMID Version="1">24069288</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2007 Jan;89(1-3):129-39</RefSource>
                <PMID Version="1">17095194</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2013 Apr;202(4):277-83</RefSource>
                <PMID Version="1">22955006</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMJ Open. 2016 Mar 01;6(3):e008721</RefSource>
                <PMID Version="1">26932138</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatr Danub. 2010 Nov;22 Suppl 1:S72-84</RefSource>
                <PMID Version="1">21057408</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>N Engl J Med. 2007 Jan 11;356(2):148-56</RefSource>
                <PMID Version="1">17215532</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2006 Jan 1;81(1):75-82</RefSource>
                <PMID Version="1">16309892</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2001 Apr;31(3):381-400</RefSource>
                <PMID Version="1">11305847</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry Suppl. 2005 Aug;48:s24-8</RefSource>
                <PMID Version="1">16055803</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Psychiatry. 2011 Sep 30;11:157</RefSource>
                <PMID Version="1">21961829</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry Suppl. 1998;172(33):53-9</RefSource>
                <PMID Version="1">9764127</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Soc Psychiatry Psychiatr Epidemiol. 2002 Jul;37(7):329-35</RefSource>
                <PMID Version="1">12111025</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2014 Feb;152(2-3):400-7</RefSource>
                <PMID Version="1">24377700</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Early Interv Psychiatry. 2017 Jun 14;:null</RefSource>
                <PMID Version="1">28613411</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Early Interv Psychiatry. 2017 Apr;11(2):123-132</RefSource>
                <PMID Version="1">25583091</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2017 Jan;247:336-344</RefSource>
                <PMID Version="1">27984822</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2001 Feb;178:160-5</RefSource>
                <PMID Version="1">11157430</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Clin Epidemiol. 1996 Dec;49(12):1373-9</RefSource>
                <PMID Version="1">8970487</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Soc Psychiatry Psychiatr Epidemiol. 2006 Dec;41(12):967-74</RefSource>
                <PMID Version="1">17036265</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2011 Aug 30;189(1):33-7</RefSource>
                <PMID Version="1">21196051</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>BMC Psychiatry. 2009 Aug 12;9:51</RefSource>
                <PMID Version="1">19674459</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2001 Dec 1;50(11):884-97</RefSource>
                <PMID Version="1">11743943</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2010 Mar;40(3):353-8</RefSource>
                <PMID Version="1">20120515</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">At risk mental state</Keyword>
            <Keyword MajorTopicYN="N">First episode psychosis</Keyword>
            <Keyword MajorTopicYN="N">Pathways to care</Keyword>
            <Keyword MajorTopicYN="N">Prodromal services</Keyword>
            <Keyword MajorTopicYN="N">Retrospective</Keyword>
            <Keyword MajorTopicYN="N">Transition to psychosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>06</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>08</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28841826</ArticleId>
            <ArticleId IdType="doi">10.1186/s12888-017-1468-y</ArticleId>
            <ArticleId IdType="pii">10.1186/s12888-017-1468-y</ArticleId>
            <ArticleId IdType="pmc">PMC5574213</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">28826999</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2509</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Schizophrenia research</Title>
                <ISOAbbreviation>Schizophr. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Not just risk: there is also resilience and we should understand its neurobiological basis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0920-9964(17)30497-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.schres.2017.08.021</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, PO 40, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, United Kingdom. Electronic address: paola.dazzan@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>08</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Schizophr Res</MedlineTA>
            <NlmUniqueID>8804207</NlmUniqueID>
            <ISSNLinking>0920-9964</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Connectivity</Keyword>
            <Keyword MajorTopicYN="N">Psychosis</Keyword>
            <Keyword MajorTopicYN="N">Resilience</Keyword>
            <Keyword MajorTopicYN="N">Resting state</Keyword>
            <Keyword MajorTopicYN="N">Schizophrenia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>08</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>08</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28826999</ArticleId>
            <ArticleId IdType="pii">S0920-9964(17)30497-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.schres.2017.08.021</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">28642258</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>06</Month>
            <Day>23</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1472-1465</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>211</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The British journal of psychiatry : the journal of mental science</Title>
                <ISOAbbreviation>Br J Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ethnicity and long-term course and outcome of psychotic disorders in a UK sample: the ÆSOP-10 study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>88-94</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1192/bjp.bp.116.193342</ELocationID>
            <Abstract>
                <AbstractText>BackgroundThe incidence of psychotic disorders is elevated in some minority ethnic populations. However, we know little about the outcome of psychoses in these populations.AimsTo investigate patterns and determinants of long-term course and outcome of psychoses by ethnic group following a first episode.MethodÆSOP-10 is a 10-year follow-up of an ethnically diverse cohort of 532 individuals with first-episode psychosis identified in the UK. Information was collected, at baseline, on clinical presentation and neurodevelopmental and social factors and, at follow-up, on course and outcome.ResultsThere was evidence that, compared with White British, Black Caribbean patients experienced worse clinical, social and service use outcomes and Black African patients experienced worse social and service use outcomes. There was evidence that baseline social disadvantage contributed to these disparities.ConclusionsThese findings suggest ethnic disparities in the incidence of psychoses extend, for some groups, to worse outcomes in multiple domains.</AbstractText>
                <CopyrightInformation>© The Royal College of Psychiatrists 2017.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Craig</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK craig.morgan@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fearon</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lappin</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heslin</LastName>
                    <ForeName>Margaret</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donoghue</LastName>
                    <ForeName>Kim</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lomas</LastName>
                    <ForeName>Ben</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reininghaus</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Onyejiaka</LastName>
                    <ForeName>Adanna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Croudace</LastName>
                    <ForeName>Tim</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jones</LastName>
                    <ForeName>Peter B</ForeName>
                    <Initials>PB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doody</LastName>
                    <ForeName>Gillian A</ForeName>
                    <Initials>GA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Craig Morgan, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Paul Fearon, MRCPsych, Department of Psychiatry, Trinity College Dublin, Dublin, Ireland; Julia Lappin, MRCPsych, School of Psychiatry, University of New South Wales, Randwick, New South Wales, Australia; Margaret Heslin, MSc, Kim Donoghue, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Ben Lomas, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Ulrich Reininghaus, PhD, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK and School of Mental Health and Neuroscience, Maastricht University, The Netherlands; Adanna Onyejiaka, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, UK; Tim Croudace, PhD, School of Nursing and Midwifery, University of Dundee, UK; Peter B. Jones, FRCPsych, Department of Psychiatry, University of Cambridge, Cambridge, UK; Robin M. Murray, FRS, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK; Gillian A. Doody, MRCPsych, Division of Psychiatry, University of Nottingham, Nottingham, UK; Paola Dazzan, MRCPsych, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London and National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>06</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Br J Psychiatry</MedlineTA>
            <NlmUniqueID>0342367</NlmUniqueID>
            <ISSNLinking>0007-1250</ISSNLinking>
        </MedlineJournalInfo>
        <CoiStatement>Declaration of interestNone.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2017</Year>
                <Month>04</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>04</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>6</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>6</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>6</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28642258</ArticleId>
            <ArticleId IdType="pii">bjp.bp.116.193342</ArticleId>
            <ArticleId IdType="doi">10.1192/bjp.bp.116.193342</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">28754583</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>07</Month>
            <Day>29</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>07</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2509</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Jul</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Schizophrenia research</Title>
                <ISOAbbreviation>Schizophr. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0920-9964(17)30453-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.schres.2017.07.042</ELocationID>
            <Abstract>
                <AbstractText>There has been much recent debate concerning the relative clinical utility of symptom dimensions versus conventional diagnostic categories in patients with psychosis. We investigated whether symptom dimensions rated at presentation for first-episode psychosis (FEP) better predicted time to first remission than categorical diagnosis over a four-year follow-up. The sample comprised 193 FEP patients aged 18-65years who presented to psychiatric services in South London, UK, between 2006 and 2010. Psychopathology was assessed at baseline with the Positive and Negative Syndrome Scale and five symptom dimensions were derived using Wallwork/Fortgang's model; baseline diagnoses were grouped using DSM-IV codes. Time to start of first remission was ascertained from clinical records. The Bayesian Information Criterion (BIC) was used to find the best fitting accelerated failure time model of dimensions, diagnoses and time to first remission. Sixty percent of patients remitted over the four years following first presentation to psychiatric services, and the average time to start of first remission was 18.3weeks (SD=26.0, median=8). The positive (BIC=166.26), excited (BIC=167.30) and disorganised/concrete (BIC=168.77) symptom dimensions, and a diagnosis of schizophrenia (BIC=166.91) predicted time to first remission. However, a combination of the DSM-IV diagnosis of schizophrenia with all five symptom dimensions led to the best fitting model (BIC=164.35). Combining categorical diagnosis with symptom dimension scores in FEP patients improved the accuracy of predicting time to first remission. Thus our data suggest that the decision to consign symptom dimensions to an annexe in DSM-5 should be reconsidered at the earliest opportunity.</AbstractText>
                <CopyrightInformation>Copyright © 2017 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ajnakina</LastName>
                    <ForeName>Olesya</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lally</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; Department of Psychiatry, School of Medicine and Medical Sciences, University College Dublin, St Vincent's Hospital, Dublin, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Forti</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC Social, Genetic &amp; Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stilo</LastName>
                    <ForeName>Simona A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolliakou</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gardner-Sood</LastName>
                    <ForeName>Poonam</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reis Marques</LastName>
                    <ForeName>Tiago</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>MacCabe</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaughran</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stamate</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Data Science &amp; Soft Computing Lab, and Department of Computing, Goldsmiths College, University of London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fisher</LastName>
                    <ForeName>Helen L</ForeName>
                    <Initials>HL</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC Social, Genetic &amp; Developmental Psychiatry Centre, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK. Electronic address: helen.2.fisher@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>07</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Schizophr Res</MedlineTA>
            <NlmUniqueID>8804207</NlmUniqueID>
            <ISSNLinking>0920-9964</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Accelerated failure time model</Keyword>
            <Keyword MajorTopicYN="N">Diagnosis</Keyword>
            <Keyword MajorTopicYN="N">Psychosis</Keyword>
            <Keyword MajorTopicYN="N">Remission</Keyword>
            <Keyword MajorTopicYN="N">Schizophrenia</Keyword>
            <Keyword MajorTopicYN="N">Symptom dimensions</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>05</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2017</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28754583</ArticleId>
            <ArticleId IdType="pii">S0920-9964(17)30453-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.schres.2017.07.042</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">28681264</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>07</Month>
            <Day>06</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>07</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1433-9285</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Jul</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Social psychiatry and psychiatric epidemiology</Title>
                <ISOAbbreviation>Soc Psychiatry Psychiatr Epidemiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00127-017-1417-6</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Previous research has not provided us with a comprehensive picture of the longitudinal course of psychotic disorders in Black people living in Europe. We sought to investigate clinical outcomes and pattern of care in Black African and Black Caribbean groups compared with White British patients during the first 5 years after first contact with mental health services for psychosis.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">245 FEP cases aged 18-65 who presented to psychiatric services in 2005-2010 in South London (UK). Using the electronic psychiatric clinical notes in the South London and Maudsley NHS Foundation Trust (SLaM), extensive information was collected on three domains-clinical, social, and service use.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">During the 5-year follow-up (mean = 5.1 years, s.d. = 2.4; 1251 person years) after first contact with mental health services, a higher proportion of Black African and Black Caribbean ethnicity had compulsory re-admissions (χ (2) = 17.34, p = 0.002) and instances of police involvement during an admission to a psychiatric unit (χ (2) = 22.82, p &lt; 0.001) compared with White British ethnic group. Patients of Black African and Black Caribbean ethnicity did not differ from the ethnic group in overall functional disability and illness severity, or frequency of remission or recovery during the follow-up period. However, patients of Black ethnicity become increasing socially excluded as their illness progress.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The longitudinal trajectory of psychosis in patients of Black ethnicity did not show greater clinical or functional deterioration than white patients. However, their course remains characterised by more compulsion, and longer periods of admission.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ajnakina</LastName>
                    <ForeName>Olesya</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3987-1236</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK. olesya.ajnakina@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lally</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Royal College of Surgeons in Ireland, Beaumont Hospital, 123 St Stephen's Green, Dublin 2, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Forti</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolliakou</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gardner-Sood</LastName>
                    <ForeName>Poonam</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lopez-Morinigo</LastName>
                    <ForeName>Javier</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>MacCabe</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaughran</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vassos</LastName>
                    <ForeName>Evangelos</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>07</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Soc Psychiatry Psychiatr Epidemiol</MedlineTA>
            <NlmUniqueID>8804358</NlmUniqueID>
            <ISSNLinking>0933-7954</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Clinical outcomes</Keyword>
            <Keyword MajorTopicYN="N">Ethnic minorities</Keyword>
            <Keyword MajorTopicYN="N">Ethnicity</Keyword>
            <Keyword MajorTopicYN="N">First episode psychosis</Keyword>
            <Keyword MajorTopicYN="N">Longitudinal outcomes</Keyword>
            <Keyword MajorTopicYN="N">Pattern of care</Keyword>
            <Keyword MajorTopicYN="N">Social isolation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>08</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28681264</ArticleId>
            <ArticleId IdType="doi">10.1007/s00127-017-1417-6</ArticleId>
            <ArticleId IdType="pii">10.1007/s00127-017-1417-6</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">28454915</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>04</Month>
            <Day>29</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>06</Month>
            <Day>27</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2215-0374</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The lancet. Psychiatry</Title>
                <ISOAbbreviation>Lancet Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Brain microglia in psychiatric disorders.</ArticleTitle>
            <Pagination>
                <MedlinePgn>563-572</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S2215-0366(17)30101-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S2215-0366(17)30101-3</ELocationID>
            <Abstract>
                <AbstractText>The role of immune activation in psychiatric disorders has attracted considerable attention over the past two decades, contributing to the rise of a new era for psychiatry. Microglia, the macrophages of the brain, are progressively becoming the main focus of the research in this field. In this Review, we assess the literature on microglia activation across different psychiatric disorders, including post-mortem and in-vivo studies in humans and experimental studies in animals. Although microglia activation has been noted in all types of psychiatric disorder, no association was seen with specific diagnostic categories. Furthermore, the findings from these studies highlight that not all psychiatric patients have microglial activation. Therefore, the cause of the neuroinflammation in these cohorts and its implications are unclear. We discuss psychosocial stress as one of the main factors determining microglial activation in patients with psychiatric disorders, and explore the relevance of these findings for future treatment strategies.</AbstractText>
                <CopyrightInformation>Copyright © 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK. Electronic address: valeria.mondelli@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vernon</LastName>
                    <ForeName>Anthony C</ForeName>
                    <Initials>AC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; MRC Centre for Neurodevelopmental Disorders, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turkheimer</LastName>
                    <ForeName>Federico</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; MRC Centre for Neurodevelopmental Disorders, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>04</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet Psychiatry</MedlineTA>
            <NlmUniqueID>101638123</NlmUniqueID>
            <ISSNLinking>2215-0366</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2017</Year>
                <Month>01</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>01</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>4</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>4</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>4</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28454915</ArticleId>
            <ArticleId IdType="pii">S2215-0366(17)30101-3</ArticleId>
            <ArticleId IdType="doi">10.1016/S2215-0366(17)30101-3</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">28498587</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>05</Month>
            <Day>12</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1723-8617</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>16</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Jun</Month>
                    </PubDate>
                </JournalIssue>
                <Title>World psychiatry : official journal of the World Psychiatric Association (WPA)</Title>
                <ISOAbbreviation>World Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Does neuroimaging have a role in predicting outcomes in psychosis?</ArticleTitle>
            <Pagination>
                <MedlinePgn>209-210</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/wps.20426</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>McGuire</LastName>
                    <ForeName>Philip</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>World Psychiatry</MedlineTA>
            <NlmUniqueID>101189643</NlmUniqueID>
            <ISSNLinking>1723-8617</ISSNLinking>
        </MedlineJournalInfo>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2014 Apr;44(6):1279-91</RefSource>
                <PMID Version="1">23866084</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Brain Mapp. 2009 Feb;30(2):355-68</RefSource>
                <PMID Version="1">18064586</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2012 May;42(5):1037-47</RefSource>
                <PMID Version="1">22059690</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2014 Mar 1;75(5):e11-3</RefSource>
                <PMID Version="1">23890739</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>JAMA Psychiatry. 2013 Oct;70(10):1031-40</RefSource>
                <PMID Version="1">23945954</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry Suppl. 1996 Dec;(31):5-9</RefSource>
                <PMID Version="1">8968649</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 2015 May;41(3):574-83</RefSource>
                <PMID Version="1">25800248</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain. 2014 Jan;137(Pt 1):172-82</RefSource>
                <PMID Version="1">24253201</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Brain Mapp. 2010 Aug;31(8):1183-95</RefSource>
                <PMID Version="1">20063303</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2006 Oct;189:381-2</RefSource>
                <PMID Version="1">17012664</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28498587</ArticleId>
            <ArticleId IdType="doi">10.1002/wps.20426</ArticleId>
            <ArticleId IdType="pmc">PMC5428193</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">28473319</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>05</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1472-1465</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2017</Year>
                        <Month>May</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The British journal of psychiatry : the journal of mental science</Title>
                <ISOAbbreviation>Br J Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinical utility of magnetic resonance imaging in first-episode psychosis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">bjp.bp.116.195834</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1192/bjp.bp.116.195834</ELocationID>
            <Abstract>
                <AbstractText>BackgroundThere is no consensus as to whether magnetic resonance imaging (MRI) should be used as part of the initial clinical evaluation of patients with first-episode psychosis (FEP).Aims(a) To assess the logistical feasibility of routine MRI; (b) to define the clinical significance of radiological abnormalities in patients with FEP.MethodRadiological reports from MRI scans of two FEP samples were reviewed; one comprised 108 patients and 98 healthy controls recruited to a research study and the other comprised 241 patients scanned at initial clinical presentation plus 66 healthy controls.ResultsIn the great majority of patients, MRI was logistically feasible. Radiological abnormalities were reported in 6% of the research sample and in 15% of the clinical sample (odds ratio (OR) = 3.1, 95% CI 1.26-7.57, χ(2)(1) = 6.63, P = 0.01). None of the findings necessitated a change in clinical management.ConclusionsRates of neuroradiological abnormalities in FEP are likely to be underestimated in research samples that often exclude patients with organic abnormalities. However, the majority of findings do not require intervention.</AbstractText>
                <CopyrightInformation>© The Royal College of Psychiatrists 2017.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Falkenberg</LastName>
                    <ForeName>Irina</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK irina.falkenberg@med.uni-marburg.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benetti</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raffin</LastName>
                    <ForeName>Marie</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wuyts</LastName>
                    <ForeName>Phillipe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pettersson-Yeo</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Kevin D</ForeName>
                    <Initials>KD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reis Marques</LastName>
                    <ForeName>Tiago</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jarosz</LastName>
                    <ForeName>Jozef</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simmons</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Steve</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGuire</LastName>
                    <ForeName>Philip</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Irina Falkenberg, MD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK and Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; Stefania Benetti, PhD, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Marie Raffin, MD, Department of Child and Adolescent Psychiatry, Université Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Paris, France; Phillipe Wuyts, MD, EDHEC Business School, Nice, France; William Pettersson-Yeo, PhD, Paola Dazzan, MBChB, MSc, MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Kevin D. Morgan, PhD, Department of Psychology, University of Westminster, London, UK; Robin M. Murray, MBChB, MPhil, FRCPsych, Tiago Reis Marques, PhD, Anthony S. David, FRCP, FRCPsych, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Jozef Jarosz, MD, Department of Neuroimaging, South London and Maudsley NHS Foundation Trust, London and Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Andrew Simmons, PhD, Steve Williams, Professor, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; Philip McGuire, Professor, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>05</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Br J Psychiatry</MedlineTA>
            <NlmUniqueID>0342367</NlmUniqueID>
            <ISSNLinking>0007-1250</ISSNLinking>
        </MedlineJournalInfo>
        <CoiStatement>Declaration of interestNone.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>04</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2017</Year>
                <Month>02</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>02</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28473319</ArticleId>
            <ArticleId IdType="pii">bjp.bp.116.195834</ArticleId>
            <ArticleId IdType="doi">10.1192/bjp.bp.116.195834</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">28009070</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>12</Month>
            <Day>23</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>09</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-0193</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>38</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Human brain mapping</Title>
                <ISOAbbreviation>Hum Brain Mapp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1833-1845</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/hbm.23485</ELocationID>
            <Abstract>
                <AbstractText>The dopaminergic system plays a key role in motor function and motor abnormalities have been shown to be a specific feature of psychosis. Due to their dopaminergic action, antipsychotic drugs may be expected to modulate motor function, but the precise effects of these drugs on motor function remain unclear. We carried out a within-subject, double-blind, randomized study of the effects of aripiprazole, haloperidol and placebo on motor function in 20 healthy men. For each condition, motor performance on an auditory-paced task was investigated. We entered maps of neural activation into a random effects general linear regression model to investigate motor function main effects. Whole-brain imaging revealed a significant treatment effect in a distributed network encompassing posterior orbitofrontal/anterior insula cortices, and the inferior temporal and postcentral gyri. Post-hoc comparison of treatments showed neural activation after aripiprazole did not differ significantly from placebo in either voxel-wise or region of interest analyses, with the results above driven primarily by haloperidol. We also observed a simple main effect of haloperidol compared with placebo, with increased task-related recruitment of posterior cingulate and precentral gyri. Furthermore, region of interest analyses revealed greater activation following haloperidol compared with placebo in the precentral and post-central gyri, and the putamen. These diverse modifications in cortical motor activation may relate to the different pharmacological profiles of haloperidol and aripiprazole, although the specific mechanisms underlying these differences remain unclear. Evaluating healthy individuals can allow investigation of the effects of different antipsychotics on cortical activation, independently of either disease-related pathology or previous treatment. Hum Brain Mapp 38:1833-1845, 2017. © 2017 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>© 2016 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Goozee</LastName>
                    <ForeName>Rhianna</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7923-5480</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Daly</LastName>
                    <ForeName>Owen</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Neuroimaging Sciences (CNS), King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Handley</LastName>
                    <ForeName>Rowena</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bristol-Myers Squibb, New York, New York.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reis Marques</LastName>
                    <ForeName>Tiago</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taylor</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McQueen</LastName>
                    <ForeName>Grant</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hubbard</LastName>
                    <ForeName>Kathryn</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinders</LastName>
                    <ForeName>Antje A T S</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MRC_G108/603</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MRC_MR/J002739/1</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Brain Mapp</MedlineTA>
            <NlmUniqueID>9419065</NlmUniqueID>
            <ISSNLinking>1065-9471</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">antipsychotic</Keyword>
            <Keyword MajorTopicYN="N">functional neuroimaging</Keyword>
            <Keyword MajorTopicYN="N">motor</Keyword>
            <Keyword MajorTopicYN="N">schizophrenia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>05</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28009070</ArticleId>
            <ArticleId IdType="doi">10.1002/hbm.23485</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27765268</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2017</Year>
            <Month>09</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2402</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>81</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Mar</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biological psychiatry</Title>
                <ISOAbbreviation>Biol. Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>470-477</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0006-3223(16)32664-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopsych.2016.06.028</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Polygenic risk scores (PRSs) have successfully summarized genome-wide effects of genetic variants in schizophrenia with significant predictive power. In a clinical sample of first-episode psychosis (FEP) patients, we estimated the ability of PRSs to discriminate case-control status and to predict the development of schizophrenia as opposed to other psychoses.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The sample (445 case and 265 control subjects) was genotyped on the Illumina HumanCore Exome BeadChip with an additional 828 control subjects of African ancestry genotyped on the Illumina Multi-Ethnic Genotyping Array. To calculate PRSs, we used the results from the latest Psychiatric Genomics Consortium schizophrenia meta-analysis. We examined the association of PRSs with case-control status and with schizophrenia versus other psychoses in European and African ancestry FEP patients and in a second sample of 248 case subjects with chronic psychosis.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">PRS had good discriminative ability of case-control status in FEP European ancestry individuals (9.4% of the variance explained, p &lt; 10(-6)), but lower in individuals of African ancestry (R(2) = 1.1%, p = .004). Furthermore, PRS distinguished European ancestry case subjects who went on to acquire a schizophrenia diagnosis from those who developed other psychotic disorders (R(2) = 9.2%, p = .002).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PRS was a powerful predictor of case-control status in a European sample of patients with FEP, even though a large proportion did not have an established diagnosis of schizophrenia at the time of assessment. PRS was significantly different between those case subjects who developed schizophrenia from those who did not, although the discriminative accuracy may not yet be sufficient for clinical utility in FEP.</AbstractText>
                <CopyrightInformation>Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Vassos</LastName>
                    <ForeName>Evangelos</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom. Electronic address: evangelos.vassos@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Forti</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Coleman</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iyegbe</LastName>
                    <ForeName>Conrad</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prata</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Euesden</LastName>
                    <ForeName>Jack</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Reilly</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Curtis</LastName>
                    <ForeName>Charles</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kolliakou</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Psychological Medicine, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Hamel</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Newhouse</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Traylor</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ajnakina</LastName>
                    <ForeName>Olesya</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Psychological Medicine, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marques</LastName>
                    <ForeName>Tiago Reis</ForeName>
                    <Initials>TR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gardner-Sood</LastName>
                    <ForeName>Poonam</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aitchison</LastName>
                    <ForeName>Katherine J</ForeName>
                    <Initials>KJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; Psychological Medicine, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Powell</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Basic and Clinical Neuroscience; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Atakan</LastName>
                    <ForeName>Zerrin</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenwood</LastName>
                    <ForeName>Kathryn E</ForeName>
                    <Initials>KE</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Psychology, University of Sussex, Brighton and Sussex Partnership National Health Service Foundation Trust, West Sussex.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Shubulade</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; South London and Maudsley National Health Service Foundation Trust, London; United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ismail</LastName>
                    <ForeName>Khalida</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Psychological Medicine, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Psychological Medicine, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaughran</LastName>
                    <ForeName>Fiona</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Markus</LastName>
                    <ForeName>Hugh S</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Neurosciences, Neurology Unit, University of Cambridge, Cambridge, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lewis</LastName>
                    <ForeName>Cathryn M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychosis Studies, Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Breen</LastName>
                    <ForeName>Gerome</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Council, Social, Genetic &amp; Developmental Psychiatry Centre; Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, United Kingdom; National Institute for Health Research Mental Health Biomedical Research Centre, South London and Maudsley National Health Service Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MRC_G108/603</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MRC_MR/J002739/1</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MRC_MR/M008436/1</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biol Psychiatry</MedlineTA>
            <NlmUniqueID>0213264</NlmUniqueID>
            <ISSNLinking>0006-3223</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044383" MajorTopicYN="N">African Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044465" MajorTopicYN="N">European Continental Ancestry Group</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D020412" MajorTopicYN="Y">Multifactorial Inheritance</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GWAS</Keyword>
            <Keyword MajorTopicYN="N">Genetics</Keyword>
            <Keyword MajorTopicYN="N">Polygenic score</Keyword>
            <Keyword MajorTopicYN="N">Psychosis</Keyword>
            <Keyword MajorTopicYN="N">Risk prediction</Keyword>
            <Keyword MajorTopicYN="N">Schizophrenia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>10</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>01</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>10</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27765268</ArticleId>
            <ArticleId IdType="pii">S0006-3223(16)32664-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopsych.2016.06.028</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">28007987</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>12</Month>
            <Day>23</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2017</Year>
            <Month>05</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2017</Year>
            <Month>09</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-2156</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>140</Volume>
                    <Issue>Pt 2</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Feb</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Brain : a journal of neurology</Title>
                <ISOAbbreviation>Brain</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Connectomic correlates of response to treatment in first-episode psychosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>487-496</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/aww297</ELocationID>
            <Abstract>
                <AbstractText>Connectomic approaches using diffusion tensor imaging have contributed to our understanding of brain changes in psychosis, and could provide further insights into the neural mechanisms underlying response to antipsychotic treatment. We here studied the brain network organization in patients at their first episode of psychosis, evaluating whether connectome-based descriptions of brain networks predict response to treatment, and whether they change after treatment. Seventy-six patients with a first episode of psychosis and 74 healthy controls were included. Thirty-three patients were classified as responders after 12 weeks of antipsychotic treatment. Baseline brain structural networks were built using whole-brain diffusion tensor imaging tractography, and analysed using graph analysis and network-based statistics to explore baseline characteristics of patients who subsequently responded to treatment. A subgroup of 43 patients was rescanned at the 12-week follow-up, to study connectomic changes over time in relation to treatment response. At baseline, those subjects who subsequently responded to treatment, compared to those that did not, showed higher global efficiency in their structural connectomes, a network configuration that theoretically facilitates the flow of information. We did not find specific connectomic changes related to treatment response after 12 weeks of treatment. Our data suggest that patients who have an efficiently-wired connectome at first onset of psychosis show a better subsequent response to antipsychotics. However, response is not accompanied by specific structural changes over time detectable with this method.</AbstractText>
                <CopyrightInformation>© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Crossley</LastName>
                    <ForeName>Nicolas A</ForeName>
                    <Initials>NA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK nicolas.crossley@kcl.ac.uk tiago.marques@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Diagonal Paraguay 362, Santiago 8330077, Chile.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marques</LastName>
                    <ForeName>Tiago Reis</ForeName>
                    <Initials>TR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK nicolas.crossley@kcl.ac.uk tiago.marques@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Du Cane Road, London, W12 0NN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taylor</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chaddock</LastName>
                    <ForeName>Chris</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dell'Acqua</LastName>
                    <ForeName>Flavio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinders</LastName>
                    <ForeName>Antje A T S</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>DiForti</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simmons</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kapur</LastName>
                    <ForeName>Shitij</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, De Crespigny Park, London SE5 8AF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MRC_G0701748</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MRC_G108/603</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
                <Grant>
                    <GrantID>MRC_MR/J002739/1</GrantID>
                    <Agency>Medical Research Council</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Brain</MedlineTA>
            <NlmUniqueID>0372537</NlmUniqueID>
            <ISSNLinking>0006-8950</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063132" MajorTopicYN="N">Connectome</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009434" MajorTopicYN="N">Neural Pathways</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">DTI</Keyword>
            <Keyword MajorTopicYN="Y">antipsychotics</Keyword>
            <Keyword MajorTopicYN="Y">connectome</Keyword>
            <Keyword MajorTopicYN="Y">first-episode psychosis</Keyword>
            <Keyword MajorTopicYN="Y">schizophrenia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>06</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>5</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28007987</ArticleId>
            <ArticleId IdType="pii">aww297</ArticleId>
            <ArticleId IdType="doi">10.1093/brain/aww297</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">28130002</PMID>
        <DateCreated>
            <Year>2017</Year>
            <Month>01</Month>
            <Day>28</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>01</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-2509</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Jan</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Schizophrenia research</Title>
                <ISOAbbreviation>Schizophr. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0920-9964(17)30047-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.schres.2017.01.034</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Neurological soft signs (NSS) are proposed to represent both state- and trait-related features of schizophrenia.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">We assessed the course of NSS with the Neurological Evaluation Scale (NES) over 12months of standardised treatment in 126 patients with first-episode schizophrenia, schizophreniform or schizoaffective disorder, and evaluated their state- and trait-related associations with psychopathology, functionality, cognition and antipsychotic treatment. We considered change scores from baseline to be state-related and endpoint scores to be trait-related.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Significant effects for time were recorded for all NSS domains. For state-related change-scores greater improvements in sensory integration were predicted by more improvement in working memory (p=0.01); greater improvements in motor sequencing scores were predicted by more improvement in working memory (p=0.005) and functionality (p=0.005); and greater improvements in NES Total score were predicted by more improvement in disorganised symptoms (p=0.02). There were more substantial associations between trait-related endpoint scores than for state-related change scores. For endpoint scores lower composite cognitive score predicted poorer sensory integration (p=0.001); higher Parkinsonism score predicted poorer motor co-ordination (p=0.0001); lower composite cognitive score (p=0.001) and higher Parkinsonism score (p=0.005) predicted poorer motor sequencing; higher Parkinsonism score (p=0.0001) and disorganised symptoms (p=0.04), and lower composite cognitive score (p=0.0007) predicted higher NES total score.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NSS improved with treatment, but were weakly associated with improvements in psychopathology. Studies investigating NSS as trait-markers should ensure that patients have been optimally treated at the time of testing, and should take possible effects of extrapyramidal symptoms into account.</AbstractText>
                <CopyrightInformation>Copyright © 2017 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Emsley</LastName>
                    <ForeName>Robin</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa. Electronic address: rae@sun.ac.za.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chiliza</LastName>
                    <ForeName>Bonginkosi</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Asmal</LastName>
                    <ForeName>Laila</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kilian</LastName>
                    <ForeName>Sanja</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Riaan Olivier</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Phahladira</LastName>
                    <ForeName>Lebogang</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ojagbemi</LastName>
                    <ForeName>Akinsola</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, University of Ibadan, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scheffler</LastName>
                    <ForeName>Freda</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carr</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Neurology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kidd</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Statistical Consultation, Stellenbosch University, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Psychosis Studies Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2017</Year>
                <Month>01</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Schizophr Res</MedlineTA>
            <NlmUniqueID>8804207</NlmUniqueID>
            <ISSNLinking>0920-9964</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Depot</Keyword>
            <Keyword MajorTopicYN="N">Flupenthixol</Keyword>
            <Keyword MajorTopicYN="N">Neurological</Keyword>
            <Keyword MajorTopicYN="N">Outcome</Keyword>
            <Keyword MajorTopicYN="N">Psychosis</Keyword>
            <Keyword MajorTopicYN="N">Schizophrenia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2017</Year>
                <Month>01</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2017</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2017</Year>
                <Month>1</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2017</Year>
                <Month>1</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>1</Month>
                <Day>29</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">28130002</ArticleId>
            <ArticleId IdType="pii">S0920-9964(17)30047-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.schres.2017.01.034</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">27421184</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateCreated>
        <DateRevised>
            <Year>2017</Year>
            <Month>02</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1095-9572</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>145</Volume>
                    <Issue>Pt B</Issue>
                    <PubDate>
                        <Year>2017</Year>
                        <Month>Jan</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>NeuroImage</Title>
                <ISOAbbreviation>Neuroimage</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>246-253</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1053-8119(16)30334-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuroimage.2016.07.027</ELocationID>
            <Abstract>
                <AbstractText>Structural Magnetic Resonance Imaging (MRI) studies have attempted to use brain measures obtained at the first-episode of psychosis to predict subsequent outcome, with inconsistent results. Thus, there is a real need to validate the utility of brain measures in the prediction of outcome using large datasets, from independent samples, obtained with different protocols and from different MRI scanners. This study had three main aims: 1) to investigate whether structural MRI data from multiple centers can be combined to create a machine-learning model able to predict a strong biological variable like sex; 2) to replicate our previous finding that an MRI scan obtained at first episode significantly predicts subsequent illness course in other independent datasets; and finally, 3) to test whether these datasets can be combined to generate multicenter models with better accuracy in the prediction of illness course. The multi-center sample included brain structural MRI scans from 256 males and 133 females patients with first episode psychosis, acquired in five centers: University Medical Center Utrecht (The Netherlands) (n=67); Institute of Psychiatry, Psychology and Neuroscience, London (United Kingdom) (n=97); University of São Paulo (Brazil) (n=64); University of Cantabria, Santander (Spain) (n=107); and University of Melbourne (Australia) (n=54). All images were acquired on 1.5-Tesla scanners and all centers provided information on illness course during a follow-up period ranging 3 to 7years. We only included in the analyses of outcome prediction patients for whom illness course was categorized as either &quot;continuous&quot; (n=94) or &quot;remitting&quot; (n=118). Using structural brain scans from all centers, sex was predicted with significant accuracy (89%; p&lt;0.001). In the single- or multi-center models, illness course could not be predicted with significant accuracy. However, when reducing heterogeneity by restricting the analyses to male patients only, classification accuracy improved in some samples. This study provides proof of concept that combining multi-center MRI data to create a well performing classification model is possible. However, to create complex multi-center models that perform accurately, each center should contribute a sample either large or homogeneous enough to first allow accurate classification within the single-center.</AbstractText>
                <CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nieuwenhuis</LastName>
                    <ForeName>Mireille</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: mireillen@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schnack</LastName>
                    <ForeName>Hugo G</ForeName>
                    <Initials>HG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Haren</LastName>
                    <ForeName>Neeltje E</ForeName>
                    <Initials>NE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lappin</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Craig</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, King's College, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinders</LastName>
                    <ForeName>Antje A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, King's College, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gutierrez-Tordesillas</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroimaging Unit, Technological Facilities, Valdecilla Biomedical Research Institute IDIVAL, Santander, Cantabria, Spain; CIBERSAM, Centro Investigación Biomédica en Red de Salud Mental, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roiz-Santiañez</LastName>
                    <ForeName>Roberto</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>CIBERSAM, Centro Investigación Biomédica en Red de Salud Mental, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schaufelberger</LastName>
                    <ForeName>Maristela S</ForeName>
                    <Initials>MS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Psychiatric Neuroimaging, Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Centro de Medicina Nuclear, São Paulo, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosa</LastName>
                    <ForeName>Pedro G</ForeName>
                    <Initials>PG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Psychiatric Neuroimaging, Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Centro de Medicina Nuclear, São Paulo, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zanetti</LastName>
                    <ForeName>Marcus V</ForeName>
                    <Initials>MV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Psychiatric Neuroimaging, Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Centro de Medicina Nuclear, São Paulo, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Busatto</LastName>
                    <ForeName>Geraldo F</ForeName>
                    <Initials>GF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Psychiatric Neuroimaging, Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Centro de Medicina Nuclear, São Paulo, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Crespo-Facorro</LastName>
                    <ForeName>Benedicto</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>CIBERSAM, Centro Investigación Biomédica en Red de Salud Mental, Department of Psychiatry, School of Medicine, University of Cantabria, Santander, Spain; Department of Medicine and Psychiatry, University Hospital Marques de Valdecilla, School of Medicine, University of Cantabria-IDIVAL-CIBERSAM, Santander, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGorry</LastName>
                    <ForeName>Patrick D</ForeName>
                    <Initials>PD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Melbourne Neuropsychiatry Center, University of Melbourne, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Velakoulis</LastName>
                    <ForeName>Dennis</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Melbourne Neuropsychiatry Center, University of Melbourne, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pantelis</LastName>
                    <ForeName>Christos</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Melbourne Neuropsychiatry Center, University of Melbourne, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wood</LastName>
                    <ForeName>Stephen J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Psychology, University of Birmingham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kahn</LastName>
                    <ForeName>René S</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mourao-Miranda</LastName>
                    <ForeName>Janaina</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer Science, University College London, London, UK; Max Planck University College London Centre for Computational Psychiatry and Ageing Research, University College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, UK; NIHR Mental Health Biomedical Research Center at South London and Maudsley NHS Foundation Trust and King's College, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>07</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neuroimage</MedlineTA>
            <NlmUniqueID>9215515</NlmUniqueID>
            <ISSNLinking>1053-8119</ISSNLinking>
        </MedlineJournalInfo>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry Suppl. 1989 Nov;(7):59-67</RefSource>
                <PMID Version="1">2619982</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):10-7</RefSource>
                <PMID Version="1">19751790</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2011;6(6):e21047</RefSource>
                <PMID Version="1">21712987</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2002 Nov;59(11):1002-10</RefSource>
                <PMID Version="1">12418933</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2003 Sep 15;54(6):608-15</RefSource>
                <PMID Version="1">13129655</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2006 Jun;188:510-8</RefSource>
                <PMID Version="1">16738340</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):278-83</RefSource>
                <PMID Version="1">19224108</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2003 Jun;60(6):565-71</RefSource>
                <PMID Version="1">12796219</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2009 Dec;115(2-3):191-201</RefSource>
                <PMID Version="1">19796919</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>IEEE Trans Med Imaging. 1998 Feb;17(1):87-97</RefSource>
                <PMID Version="1">9617910</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2005 Dec;162(12):2233-45</RefSource>
                <PMID Version="1">16330585</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 1999 Apr;156(4):603-9</RefSource>
                <PMID Version="1">10200741</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroinformatics. 2011 Dec;9(4):321-33</RefSource>
                <PMID Version="1">21246418</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain. 2012 May;135(Pt 5):1508-21</RefSource>
                <PMID Version="1">22544901</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Top Behav Neurosci. 2010;4:243-81</RefSource>
                <PMID Version="1">21312403</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2010 Mar 30;181(3):204-10</RefSource>
                <PMID Version="1">20153145</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2012 May;42(5):1037-47</RefSource>
                <PMID Version="1">22059690</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>World J Biol Psychiatry. 2010 Oct;11(7):873-87</RefSource>
                <PMID Version="1">20545464</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013 May 31;8(5):e64925</RefSource>
                <PMID Version="1">23741425</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Front Psychiatry. 2016 Mar 31;7:50</RefSource>
                <PMID Version="1">27064972</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2009 Mar;108(1-3):104-13</RefSource>
                <PMID Version="1">19157788</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2006 Feb;63(2):139-49</RefSource>
                <PMID Version="1">16461856</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2012 Jul 2;61(3):606-12</RefSource>
                <PMID Version="1">22507227</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2012 Jun;61(2):457-63</RefSource>
                <PMID Version="1">22094642</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Acta Psychiatr Scand Suppl. 2000;401:3-38</RefSource>
                <PMID Version="1">10887978</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2013 Jun 30;212(3):230-6</RefSource>
                <PMID Version="1">23149027</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Inf Process Med Imaging. 2009;21:300-13</RefSource>
                <PMID Version="1">19694272</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Biobehav Rev. 2012 Apr;36(4):1140-52</RefSource>
                <PMID Version="1">22305994</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry Suppl. 2007 Dec;51:s117-22</RefSource>
                <PMID Version="1">18055927</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:116-25</RefSource>
                <PMID Version="1">23261522</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2001 Jun;178:506-17</RefSource>
                <PMID Version="1">11388966</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2003 Nov 1;64(1):41-52</RefSource>
                <PMID Version="1">14511800</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 1992 Aug;49(8):615-23</RefSource>
                <PMID Version="1">1637251</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2001 Sep;14(3):685-700</RefSource>
                <PMID Version="1">11506541</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Brain Mapp. 2010 Dec;31(12):1967-82</RefSource>
                <PMID Version="1">21086550</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hastings Cent Rep. 2014 Mar-Apr;Spec No:S31-6</RefSource>
                <PMID Version="1">24634083</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 2013 Sep;39(5):1129-38</RefSource>
                <PMID Version="1">23042112</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Can J Psychiatry. 2013 Sep;58(9):499-508</RefSource>
                <PMID Version="1">24099497</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Epidemiol Psychiatr Sci. 2014 Sep;23 (3):219-25</RefSource>
                <PMID Version="1">24849668</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2014 Aug 20;9(8):e105563</RefSource>
                <PMID Version="1">25140532</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neurosci Biobehav Rev. 2012 Apr;36(4):1342-56</RefSource>
                <PMID Version="1">22244985</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatry Res. 2005 Nov 30;140(2):147-55</RefSource>
                <PMID Version="1">16256315</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2007 Jan;64(1):19-28</RefSource>
                <PMID Version="1">17199051</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2009 Dec 1;66(11):1055-60</RefSource>
                <PMID Version="1">19729150</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2005 Jul 1;26(3):839-51</RefSource>
                <PMID Version="1">15955494</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuropsychopharmacology. 2015 Jun;40(7):1742-51</RefSource>
                <PMID Version="1">25601228</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2001 Mar 15;49(6):487-99</RefSource>
                <PMID Version="1">11257234</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2006 Oct;189:381-2</RefSource>
                <PMID Version="1">17012664</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 1990 Jun;47(6):589-93</RefSource>
                <PMID Version="1">2190539</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>IEEE Trans Neural Netw. 1999;10(5):988-99</RefSource>
                <PMID Version="1">18252602</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2002 Feb;59(2):154-64</RefSource>
                <PMID Version="1">11825137</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2015</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>07</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27421184</ArticleId>
            <ArticleId IdType="pii">S1053-8119(16)30334-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroimage.2016.07.027</ArticleId>
            <ArticleId IdType="pmc">PMC5193177</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27756771</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>10</Month>
            <Day>19</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2017</Year>
            <Month>03</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2017</Year>
            <Month>08</Month>
            <Day>17</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1440-1614</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>50</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The Australian and New Zealand journal of psychiatry</Title>
                <ISOAbbreviation>Aust N Z J Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Outcomes following first-episode psychosis - Why we should intervene early in all ages, not only in youth.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1055-1063</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare baseline demographics and 10-year outcomes of a first-episode psychosis patient incidence cohort in order to establish whether current youth-focussed age-based criteria for early intervention services are justified by patient needs. The patients in this cohort were treated prior to the establishment of early intervention services. The study aimed to test the hypothesis that those who develop psychosis at a younger age have worse outcomes than those who develop psychosis at an older age.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Data on first-episode psychosis patients from the ÆSOP-10 longitudinal follow-up study were used to compare baseline characteristics, and 10-year clinical, functional and service use outcomes between those patients who would and would not have met age-based criteria for early intervention services, in Australia or in the United Kingdom.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 58% men and 71% women with first-episode psychosis were too old to meet current Australian-early intervention age-entry criteria (χ(2) = 9.1, p = 0.003), while 21% men and 34% women were too old for UK-early intervention age-entry criteria (χ(2) = 11.1, p = 0.001). The 10-year clinical and functional outcomes did not differ significantly between groups by either Australian- or UK-early intervention age-entry criteria. Service use was significantly greater among the patients young enough to meet early intervention age-criteria (Australia: incidence rate ratio = 1.35 [1.19, 1.52], p &lt; 0.001; United Kingdom: incidence rate ratio = 1.65 [1.41, 1.93], p &lt; 0.001).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Current early intervention services are gender- and age-inequitable. Large numbers of patients with first-episode psychosis will not receive early intervention care under current service provision. Illness outcomes at 10-years were no worse in first-episode psychosis patients who presented within the age range for whom early intervention has been prioritised, though these patients had greater service use. These data provide a rationale to consider extension of early intervention to all, rather than just to youth.</AbstractText>
                <CopyrightInformation>© The Royal Australian and New Zealand College of Psychiatrists 2016.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lappin</LastName>
                    <ForeName>Julia M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Psychiatry, University of New South Wales, Sydney, NSW, Australia j.lappin@unsw.edu.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heslin</LastName>
                    <ForeName>Margaret</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jones</LastName>
                    <ForeName>Peter B</ForeName>
                    <Initials>PB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, University of Cambridge, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doody</LastName>
                    <ForeName>Gillian A</ForeName>
                    <Initials>GA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, The University of Nottingham, Nottingham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reininghaus</LastName>
                    <ForeName>Ulrich A</ForeName>
                    <Initials>UA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Demjaha</LastName>
                    <ForeName>Arsime</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Croudace</LastName>
                    <ForeName>Timothy</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Nursing and Health Sciences University of Dundee, Dundee, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jamieson-Craig</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donoghue</LastName>
                    <ForeName>Kim</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lomas</LastName>
                    <ForeName>Ben</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nottingham University Hospitals NHS Trust, The University of Nottingham, Nottingham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fearon</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morgan</LastName>
                    <ForeName>Craig</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Psychiatry, Psychology &amp; Neuroscience, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>10</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Aust N Z J Psychiatry</MedlineTA>
            <NlmUniqueID>0111052</NlmUniqueID>
            <ISSNLinking>0004-8674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychiatr Serv. 1995 Nov;46(11):1166-71</RefSource>
                <PMID Version="1">8564507</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 1976 Jun;33(6):766-71</RefSource>
                <PMID Version="1">938196</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 2014 Oct;44(13):2713-26</RefSource>
                <PMID Version="1">25066181</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med Monogr Suppl. 1992;20:1-97</RefSource>
                <PMID Version="1">1565705</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2004 Mar;161(3):473-9</RefSource>
                <PMID Version="1">14992973</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Aust N Z J Psychiatry. 2016 May;50(5):410-72</RefSource>
                <PMID Version="1">27106681</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2006 Dec;88(1-3):96-101</RefSource>
                <PMID Version="1">16962742</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2006 Mar;63(3):250-8</RefSource>
                <PMID Version="1">16520429</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Australas Psychiatry. 2014 May 8;22(3):235-241</RefSource>
                <PMID Version="1">24811714</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2006 Nov;189:446-52</RefSource>
                <PMID Version="1">17077436</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychoneuroendocrinology. 2003 Apr;28 Suppl 2:17-54</RefSource>
                <PMID Version="1">12650680</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Br J Psychiatry. 2001 Jun;178:506-17</RefSource>
                <PMID Version="1">11388966</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2000 Mar 16;42(1):67-77</RefSource>
                <PMID Version="1">10706987</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2001 Dec 1;50(11):898-911</RefSource>
                <PMID Version="1">11743944</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Soc Psychiatry Psychiatr Epidemiol. 1996 Sep;31(5):249-58</RefSource>
                <PMID Version="1">8909114</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 2013 Nov;39(6):1296-306</RefSource>
                <PMID Version="1">23172003</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Early Interv Psychiatry. 2016 Mar 28;:null</RefSource>
                <PMID Version="1">27018640</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Arch Gen Psychiatry. 2005 Sep;62(9):975-83</RefSource>
                <PMID Version="1">16143729</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Ther Umsch. 2007 Jun;64(6):337-43</RefSource>
                <PMID Version="1">17877211</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D061345" MajorTopicYN="N">Early Medical Intervention</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008605" MajorTopicYN="N">Mental Health Services</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment (Health Care)</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName>
                <QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Psychosis</Keyword>
            <Keyword MajorTopicYN="Y">early intervention</Keyword>
            <Keyword MajorTopicYN="Y">outcomes</Keyword>
            <Keyword MajorTopicYN="Y">schizophrenia</Keyword>
            <Keyword MajorTopicYN="Y">women</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>3</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>11</Month>
                <Day>3</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27756771</ArticleId>
            <ArticleId IdType="pii">0004867416673454</ArticleId>
            <ArticleId IdType="doi">10.1177/0004867416673454</ArticleId>
            <ArticleId IdType="pmc">PMC5316960</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27352783</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>06</Month>
            <Day>29</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2017</Year>
            <Month>07</Month>
            <Day>24</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2017</Year>
            <Month>07</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1745-1701</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Schizophrenia bulletin</Title>
                <ISOAbbreviation>Schizophr Bull</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1446-1456</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/schbul/sbw069</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Converging evidence suggests that patients with first-episode psychosis who show a poor treatment response may have a higher degree of neurodevelopmental abnormalities than good Responders. Characterizing the disturbances in the relationship among brain regions (covariance) can provide more information on neurodevelopmental integrity than searching for localized changes in the brain. Graph-based connectomic approach can measure structural covariance thus providing information on the maturational processes. We quantified the structural covariance of cortical folding using graph theory in first-episode psychosis, to investigate if this systems-level approach would improve our understanding of the biological determinants of outcome in psychosis.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Magnetic Resonance Imaging data were acquired in 80 first-episode psychosis patients and 46 healthy controls. Response to treatment was assessed after 12 weeks of naturalistic follow-up. Gyrification-based connectomes were constructed to study the maturational organization of cortical folding.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Nonresponders showed a reduction in the distributed relationship among brain regions (high segregation, poor integration) when compared to Responders and controls, indicating a higher burden of aberrant neurodevelopment. They also showed reduced centrality of key regions (left insula and anterior cingulate cortex) indicating a marked reconfiguration of gyrification. Nonresponders showed a vulnerable pattern of covariance that disintegrated when simulated lesions removed high-degree hubs, indicating an abnormal dependence on highly central hub regions in Nonresponders.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest that a perturbed maturational relationship among brain regions underlies poor treatment response in first-episode psychosis. The information obtained from gyrification-based connectomes can be harnessed for prospectively predicting treatment response and prognosis in psychosis.</AbstractText>
                <CopyrightInformation>© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Palaniyappan</LastName>
                    <ForeName>Lena</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Psychiatry, Neuroscience and Medical Biophysics &amp; Robarts Research Institute, Western University, London, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lawson Health Research Institute, London, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marques</LastName>
                    <ForeName>Tiago Reis</ForeName>
                    <Initials>TR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taylor</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondelli</LastName>
                    <ForeName>Valeria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinders</LastName>
                    <ForeName>A A T Simone</ForeName>
                    <Initials>AATS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bonaccorso</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giordano</LastName>
                    <ForeName>Annalisa</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>DiForti</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simmons</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Anthony S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pariante</LastName>
                    <ForeName>Carmine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Robin M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dazzan</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>06</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Schizophr Bull</MedlineTA>
            <NlmUniqueID>0236760</NlmUniqueID>
            <ISSNLinking>0586-7614</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 1997 Apr;154(4):475-82</RefSource>
                <PMID Version="1">9090333</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Hum Brain Mapp. 2014 May;35(5):1885-95</RefSource>
                <PMID Version="1">23728856</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 1992;18(2):319-32</RefSource>
                <PMID Version="1">1377834</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cereb Cortex. 2013 Sep;23(9):2072-85</RefSource>
                <PMID Version="1">22784607</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 2013 Jul;39(4):820-9</RefSource>
                <PMID Version="1">22892556</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2012 Nov;141(2-3):109-18</RefSource>
                <PMID Version="1">22981811</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2013 Oct 15;80:426-44</RefSource>
                <PMID Version="1">23643999</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Dev Psychopathol. 2011 Feb;23(1):339-52</RefSource>
                <PMID Version="1">21262059</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2010 Jul 14;30(28):9477-87</RefSource>
                <PMID Version="1">20631176</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 2014 May;40(3):675-84</RefSource>
                <PMID Version="1">23615812</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2012;7(7):e40709</RefSource>
                <PMID Version="1">22808240</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2011 Dec 8;72 (5):873-84</RefSource>
                <PMID Version="1">22153381</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2012 Jan 16;59(2):1085-93</RefSource>
                <PMID Version="1">21963918</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2012 Feb 1;59(3):2196-207</RefSource>
                <PMID Version="1">22008374</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>JAMA Psychiatry. 2013 Oct;70(10):1031-40</RefSource>
                <PMID Version="1">23945954</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2005 Mar;162(3):441-9</RefSource>
                <PMID Version="1">15741458</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Front Psychiatry. 2012 Dec 06;3:105</RefSource>
                <PMID Version="1">23230425</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Psychol Med. 1999 May;29(3):621-7</RefSource>
                <PMID Version="1">10405083</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2009 Mar;10(3):186-98</RefSource>
                <PMID Version="1">19190637</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2010 Sep;52(3):1059-69</RefSource>
                <PMID Version="1">19819337</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2006 Jul 1;31(3):968-80</RefSource>
                <PMID Version="1">16530430</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2013 Nov 15;74(10):777-85</RefSource>
                <PMID Version="1">23601854</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2007 Jan;89(1-3):129-39</RefSource>
                <PMID Version="1">17095194</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Curr Top Med Chem. 2012;12(21):2393-403</RefSource>
                <PMID Version="1">23279178</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2008 Sep 10;28(37):9239-48</RefSource>
                <PMID Version="1">18784304</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Brain. 2014 Jan;137(Pt 1):172-82</RefSource>
                <PMID Version="1">24253201</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nature. 2010 Nov 11;468(7321):187-93</RefSource>
                <PMID Version="1">21068826</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>IEEE Trans Med Imaging. 2008 Feb;27(2):161-70</RefSource>
                <PMID Version="1">18334438</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>JAMA Psychiatry. 2013 Aug;70(8):783-92</RefSource>
                <PMID Version="1">23739835</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2013 Feb 13;33(7):2889-99</RefSource>
                <PMID Version="1">23407947</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Brain Res. 1980;53:1-19</RefSource>
                <PMID Version="1">7005941</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 1991 May 1;29(9):865-77</RefSource>
                <PMID Version="1">2049485</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2012 Oct 1;62(4):2296-314</RefSource>
                <PMID Version="1">22387165</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2014 Sep 15;76(6):447-55</RefSource>
                <PMID Version="1">24369266</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Am J Psychiatry. 2016 Jan;173(1):69-77</RefSource>
                <PMID Version="1">26315980</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Bull. 2004;30(2):241-53</RefSource>
                <PMID Version="1">15279043</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Biol Psychiatry. 2007 Oct 1;62(7):722-9</RefSource>
                <PMID Version="1">17509536</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2007 Feb 28;27(9):2349-56</RefSource>
                <PMID Version="1">17329432</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2013 Oct 15;80:489-504</RefSource>
                <PMID Version="1">23711536</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Cereb Cortex. 2007 Oct;17(10):2407-19</RefSource>
                <PMID Version="1">17204824</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>PLoS One. 2013 Jul 04;8(7):e68910</RefSource>
                <PMID Version="1">23861951</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Neurosci. 2010 Nov 24;30(47):15915-26</RefSource>
                <PMID Version="1">21106830</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Int Rev Psychiatry. 2007 Aug;19(4):345-57</RefSource>
                <PMID Version="1">17671868</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):948-54</RefSource>
                <PMID Version="1">18262704</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18191-6</RefSource>
                <PMID Version="1">20921389</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuron. 2013 Aug 21;79(4):814-28</RefSource>
                <PMID Version="1">23972602</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2010 Apr 15;50(3):970-83</RefSource>
                <PMID Version="1">20035887</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2013 Oct 15;80:515-26</RefSource>
                <PMID Version="1">23623973</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 2008 Feb 1;39(3):927-35</RefSource>
                <PMID Version="1">17988891</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Neuroimage. 1999 Feb;9(2):179-94</RefSource>
                <PMID Version="1">9931268</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Nat Rev Neurosci. 2013 May;14(5):322-36</RefSource>
                <PMID Version="1">23531697</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Psychiatry Neurosci. 2012 Nov;37(6):399-406</RefSource>
                <PMID Version="1">22640702</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>J Psychiatry Neurosci. 2012 Jan;37(1):17-27</RefSource>
                <PMID Version="1">21693094</PMID>
            </CommentsCorrections>
            <CommentsCorrections RefType="Cites">
                <RefSource>Schizophr Res. 2006 Oct;87(1-3):60-6</RefSource>
                <PMID Version="1">16875801</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
                <QualifierName UI="Q000002" MajorTopicYN="N">abnormalities</QualifierName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D063132" MajorTopicYN="N">Connectome</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017063" MajorTopicYN="Y">Outcome Assessment (Health Care)</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">connectome</Keyword>
            <Keyword MajorTopicYN="N">cortical folding</Keyword>
            <Keyword MajorTopicYN="N">first-episode psychosis</Keyword>
            <Keyword MajorTopicYN="N">graph theory</Keyword>
            <Keyword MajorTopicYN="N">neuroimaging</Keyword>
            <Keyword MajorTopicYN="N">surface based morphometry</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>6</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2017</Year>
                <Month>7</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>6</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27352783</ArticleId>
            <ArticleId IdType="pmc">PMC5049536</ArticleId>
            <ArticleId IdType="pii">sbw069</ArticleId>
            <ArticleId IdType="doi">10.1093/schbul/sbw069</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
